Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle D Hackshaw

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Cancer|March 23, 2016
Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinomaJennifer L Beaumont, John M Salsman, Jose Diaz, et al.
The New England Journal of Medicine|August 23, 2013
Pazopanib versus sunitinib in metastatic renal-cell carcinomaRobert J Motzer, Thomas E Hutson, David Cella, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Cancer|March 23, 2016
Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinomaJennifer L Beaumont, John M Salsman, Jose Diaz, et al.
The New England Journal of Medicine|August 23, 2013
Pazopanib versus sunitinib in metastatic renal-cell carcinomaRobert J Motzer, Thomas E Hutson, David Cella, et al.
Pageof 3